In the AHA Scientific Statement, “Infective Endocarditis: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association,” by Baddour et al (Circulation. 2005;111:e394–e434), the following corrections are needed:
Reference 136 was originally listed as the following abstract: Gavalda J, Miro J, Torres C, De La Torre Cisneros, Munoz P, Pena C, Aguado J, Montejo M, Navas E, Romeu J, Sarria C, Marco F, Almirante B, Pahissa A. Efficacy of ampicillin (A) plus ceftriaxone (Ctr) or cefotaxime (Cx) in treatment of endocarditis due to Enterococcus faecalis. In: Programs and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology; 2001:3. Abstract 1342.
The study has now been published and therefore reference 136 should read: Gavaldà J, Len O, Miró JM, Muñoz P, Montejo M, Alarcón A, de la Torre-Cisneros J, Peña C, Martínez-Lacasa X, Sarria C, Bou G, Aguado JM, Navas E, Romeu J, Marco F, Torres C, Tornos P, Planes A, Falcó V, Almirante B, Pahissa A. Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone. Ann Intern Med. 2007;146:574–579.
Reference 41 is incorrectly listed (the first author’s name was omitted). It should read: Lamas CC, Eykyn SJ. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases. Clin Infect Dis. 1997;25:713–719.
These corrections have been made to the current online version of the article, available at http://circ.ahajournals.org/cgi/content/full/111/23/e394.